![Hubert Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hubert Chen
Directeur Technique/Scientifique/R&D chez
VIKING THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Hubert C.
Chen formerly worked at Amgen, Inc., as Associate Director-Medical Sciences from 2004 to 2006, Amylin Pharmaceuticals, Inc., as Senior Director-Clinical Research, Rein Therapeutics, Inc., as Vice President-Clinical Development from 2013 to 2014, The University of California, San Francisco, as Assistant Clinical Professor from 2002 to 2012, The J.
David Gladstone Institutes, as Staff Research Investigator, Regulus Therapeutics, Inc., as Vice President-Translational Medicine from 2009 to 2012, Pelican, Inc., as Chief Medical & Scientific Officer from 2014 to 2018, Metacrine, Inc., as Chief Medical Officer from 2018 to 2021, and Forte Biosciences, Inc., as President & Chief Scientific Officer from 2022 to 2024.
Dr. Chen received his doctorate degree in 1995 from The Trustees of Columbia University in The City of New York and undergraduate degree in 1991 from Stanford University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Hubert Chen
| Sociétés | Poste | Début |
|---|---|---|
| VIKING THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 11/06/2026 |
Anciens postes connus de Hubert Chen
| Sociétés | Poste | Fin |
|---|---|---|
| FORTE BIOSCIENCES, INC. | President | 15/03/2024 |
| METACRINE, INC. | Directeur Technique/Scientifique/R&D | 31/12/2021 |
| PFENEX INC. | Directeur Technique/Scientifique/R&D | 02/09/2018 |
| REIN THERAPEUTICS INC. | Corporate Officer/Principal | 01/10/2014 |
| REGULUS THERAPEUTICS INC. | Corporate Officer/Principal | 01/01/2012 |
Formation de Hubert Chen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The J. David Gladstone Institutes
 The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | Commercial Services |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Viking Therapeutics, Inc.
 Viking Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic and endocrine disorders | Health Technology |
Metacrine, Inc.
 Metacrine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
Forte Biosciences, Inc.
 Forte Biosciences, Inc. BiotechnologyHealth Technology Provides dermatological therapies and related services | Health Technology |
